The use of drug combinations to treat cancer is expected to increase as companies begin developing and testing the combinations earlier. Traditionally, drug development focused on single drugs or the combination of an experimental therapy with an already approved product. Now, research into combinations of drugs is occurring at earlier stages because scientists are gaining a greater understanding of cancer, the human genome and how to attack the disease on multiple fronts.
